Allegheny General Hospital is a large urban hospital located at 320 East North Avenue in Pittsburgh, Pennsylvania, United States. It is part of the larger Allegheny Health Network.

There are 576 beds in Allegheny Health Network.

During the past decade, Allegheny Health Network conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 13 clinical trials were completed, i.e. on average, 27.7% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 10 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allegheny Health Network" #1 sponsor was "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 5 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored, "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allegheny Health Network" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator and "Allegheny Health Network" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Allegheny Health Network" are "Breast Cancer" (2 trials), "Degenerative Disc Disease" (2 trials), "HIV-1 Infection" (2 trials), "Healthy" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Allegheny Health Network" in a lesser frequency.

Most popular intervention types in "Allegheny Health Network" are "Drug" (29 trials), "Device" (11 trials), "Other" (6 trials), "Biological" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (5 trials), "B/F/TAF" (3 trials), "B/F/TAF Placebo" (2 trials), "Blood Sample Collection" (2 trials) and "F/TAF" (2 trials). Other intervention names were less common.

The vast majority of trials in "Allegheny Health Network" are 48 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Allegheny Health Network". undefined are not yet recruiting, 14 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Allegheny Health Network, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Allegheny Health Network, 10 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".